Literature DB >> 8994405

Small LDL, atherogenic dyslipidemia, and the metabolic syndrome.

S M Grundy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 8994405     DOI： 10.1161/01.cir.95.1.1

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  44 in total

Review 1.  Identification and treatment of hypertriglyceridemia as a risk factor for coronary heart disease.

Authors:  H N Ginsberg
Journal:  Curr Cardiol Rep       Date:  1999-09       Impact factor: 2.931

Review 2.  Small, dense low-density lipoprotein: risk or myth?

Authors:  Ngoc-Anh Le
Journal:  Curr Atheroscler Rep       Date:  2003-01       Impact factor: 5.113

Review 3.  Modern approach to the clinical management of non-alcoholic fatty liver disease.

Authors:  Maria Del Ben; Licia Polimeni; Francesco Baratta; Daniele Pastori; Lorenzo Loffredo; Francesco Angelico
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

Review 4.  Management of Dyslipidemia in Patients with Hypertension, Diabetes, and Metabolic Syndrome.

Authors:  Sundararajan Srikanth; Prakash Deedwania
Journal:  Curr Hypertens Rep       Date:  2016-10       Impact factor: 5.369

Review 5.  Influence of dietary carbohydrate and fat on LDL and HDL particle distributions.

Authors:  Patty W Siri; Ronald M Krauss
Journal:  Curr Atheroscler Rep       Date:  2005-11       Impact factor: 5.113

6.  Atherogenic Dyslipidemia Remission 1 Year After Bariatric Surgery.

Authors:  Elisenda Climent; David Benaiges; Juan Pedro-Botet; Juana A Flores-Le Roux; Jose M Ramón; Montserrat Villatoro; Laia Fontané; Juan J Chillarón; Albert Goday
Journal:  Obes Surg       Date:  2017-06       Impact factor: 4.129

Review 7.  The Forgotten Lipids: Triglycerides, Remnant Cholesterol, and Atherosclerotic Cardiovascular Disease Risk.

Authors:  Pratik B Sandesara; Salim S Virani; Sergio Fazio; Michael D Shapiro
Journal:  Endocr Rev       Date:  2019-04-01       Impact factor: 19.871

8.  Reproducible MRI measurement of adipose tissue volumes in genetic and dietary rodent obesity models.

Authors:  David H Johnson; Chris A Flask; Paul R Ernsberger; Wilbur C K Wong; David L Wilson
Journal:  J Magn Reson Imaging       Date:  2008-10       Impact factor: 4.813

Review 9.  Approach to identifying and managing atherogenic dyslipidemia: a metabolic consequence of obesity and diabetes.

Authors:  N John Bosomworth
Journal:  Can Fam Physician       Date:  2013-11       Impact factor: 3.275

Review 10.  Lipoprotein disorders and cardiovascular risk.

Authors:  J Genest
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.